(Q34543752)

2 August 2017

title

The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma (English)

1 reference

2 August 2017

N Shinohara

1

1 reference

2 August 2017

M Takahashi

2

1 reference

2 August 2017

T Kamishima

3

1 reference

2 August 2017

H Ikushima

4

1 reference

2 August 2017

N Otsuka

5

1 reference

2 August 2017

A Ishizu

6

1 reference

2 August 2017

C Shimizu

7

1 reference

2 August 2017

H Kanayama

8

1 reference

2 August 2017

K Nonomura

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

14 December 2010

1 reference

British Journal of Cancer

2 August 2017

published in

1 reference

2 August 2017

volume

104

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

241-247

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6606029

2 August 2017

exact match

0 references

cites work

A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Effect of sunitinib on growth and function of FRTL-5 thyroid cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Sunitinib in patients with metastatic renal cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Normal thyroid size versus goiter--postmortem thyroid weight and ultrasonographic volumetry versus physical examination.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606029

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606029

Thyroid dimensions of Korean adults on routine neck computed tomography and its relationship to age, sex, and body size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606029

Sunitinib induces hypothyroidism with a markedly reduced vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606029

Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: a potential marker of irreversible thyroid dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606029

Rapid estimation of split renal function in kidney donors using software developed for computed tomographic renal volumetry.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031892

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21157447

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21157447

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Thyroid volume measured by ultrasonography and CT

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21157447

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6606029

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference